261 related articles for article (PubMed ID: 22183494)
1. DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.
Shih B; Tassabehji M; Watson JS; Bayat A
Plast Reconstr Surg; 2012 Apr; 129(4):921-932. PubMed ID: 22183494
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide high-resolution screening in Dupuytren's disease reveals common regions of DNA copy number alterations.
Shih BB; Tassabehji M; Watson JS; McGrouther AD; Bayat A
J Hand Surg Am; 2010 Jul; 35(7):1172-1183.e7. PubMed ID: 20561756
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
5. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.
Major M; Freund MK; Burch KS; Mancuso N; Ng M; Furniss D; Pasaniuc B; Ophoff RA
Genet Epidemiol; 2019 Sep; 43(6):629-645. PubMed ID: 31087417
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling and Dupuytren's disease.
Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
[TBL] [Abstract][Full Text] [Related]
10. No gene copy number changes in Dupuytren's contracture by array comparative genomic hybridization.
Kaur S; Forsman M; Ryhänen J; Knuutila S; Larramendy ML
Cancer Genet Cytogenet; 2008 May; 183(1):6-8. PubMed ID: 18474290
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of WNT Signaling Pathway Gene Variants
Samulėnas G; Smalinskienė A; Rimdeika R; Braziulis K; Fomkinas M; Paškevičius R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573275
[TBL] [Abstract][Full Text] [Related]
12. SNPs previously associated with Dupuytren's disease replicated in a North American cohort.
Anderson ER; Ye Z; Caldwell MD; Burmester JK
Clin Med Res; 2014 Dec; 12(3-4):133-7. PubMed ID: 24573701
[TBL] [Abstract][Full Text] [Related]
13. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.
Mosakhani N; Guled M; Lahti L; Borze I; Forsman M; Pääkkönen V; Ryhänen J; Knuutila S
Mod Pathol; 2010 Nov; 23(11):1544-52. PubMed ID: 20676061
[TBL] [Abstract][Full Text] [Related]
14. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
[TBL] [Abstract][Full Text] [Related]
15. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
18. Association of Morbus Ledderhose with Dupuytren's contracture.
Gudmundsson KG; Jónsson T; Arngrímsson R
Foot Ankle Int; 2013 Jun; 34(6):841-5. PubMed ID: 23386754
[TBL] [Abstract][Full Text] [Related]
19. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
[TBL] [Abstract][Full Text] [Related]
20. Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren's disease.
Dal Cin P; De Smet L; Sciot R; Van Damme B; Van den Berghe H
Cancer Genet Cytogenet; 1999 Jan; 108(2):137-40. PubMed ID: 9973941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
